补充途径:糖尿病病患者心血管疾病的分子风险模式
JunFei Liu1, XiaoPing Qian1, TaoXia Wang1
1Affiliated Hospital of Hebei University of Engineering, Department of Nephrology, The Key Laboratory of Basic Research on Blood Purification Application in Hebei Province, Handan City, Hebei Province, China.
Journal of medical biochemistry
|August 21, 2025
概括
尿酸 (UA) 和C1q水平的升高是糖尿病病患者心血管疾病 (CVD) 的独立危险因素. 较高的UA和C1q水平与心血管疾病风险增加相关,有助于患者的评估.
科学领域:
- 肝脏病学
- 心脏病学
- 糖尿病学
背景情况:
- 糖尿病病 (DN) 是糖尿病的一个常见并发症,随着功能障碍的进展,心血管疾病 (CVD) 的风险会增加.
- 有效管理DN和CVD需要识别和解决共同的风险因素.
研究的目的:
- 在糖尿病病 (DN) 患者中确定心血管疾病 (CVD) 的独立风险因素.
- 研究DN患者的尿酸 (UA),C1q,C反应蛋白 (CRP) 和心血管疾病风险之间的关系.
- 评估UA和C1q在DN中对心血管疾病的预测效果.
主要方法:
- 一项涉及98名DN患者的横截面研究,分为DN (n=58) 和DN/ CVD (n=40) 组.
- 用单变量和多变量逻辑回归分析来确定心血管疾病的独立风险因素.
- 通过回归建模和ROC曲线分析,评估了UA,C1q,CRP和心血管疾病风险之间的关系.
主要成果:
- 在DN患者中,尿酸 (UA) 和C1q的升高被确定为心血管疾病的独立风险因素.
- 在UA/ C1q水平与心血管疾病风险之间观察到线性关联.
- 与UA和CRP相比,C1q对心血管疾病的预测性能更好.
结论:
- 增加UA和C1q水平显著提高了DN患者的心血管疾病风险.
- UA和C1q是评估DN中心血管疾病发展和进展的有价值指标.
- 这些标志物为DN患者的临床状况提供了支持性评估价值.
相关概念视频
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Chronic Kidney Disease II: Clinical Manifestations
87
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
87
Complement System
2.7K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
2.7K
Coronary Artery Disease I: Introduction
55
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
55
Heart Failure II: Pathophysiology
38
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
38
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
34
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
34


